Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Clinical trial NCT02961764 · COMPLETED
Trial details
- NCT number
- NCT02961764
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2019-03-29
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.